Productivity Rankings is a unique service offered only by “AD Scientific Index”. This is a ranking system derived from the i10 index in order to show the productivity of the scientist in publishing scientific articles of value. Productivity Rankings is an instrument that lists productive scientists in a given area, discipline, university, and country and can guide the development of meaningful incentives and academic policies. The world rankings, regional rankings, and university rankings of scientists in this table are developed based on the total i10 index. Click for "last 6 years' i10 index" Click for individual or institutional registration.
AD Scientific Index - World Scientists i10 Productivity Rankings - 2024 | i10 INDEX | H INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University | Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 Year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
1 | 183 | 5062 | 14478 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
transporters | drug metabolism | pharmacokinetics | |
282 | 128 | 0.454 | 61 | 35 | 0.574 | 15852 | 5019 | 0.317 |
2 | 267 | 7136 | 20319 |
|
Sweden | AstraZeneca, Sweden |
Others
|
243 | 126 | 0.519 | 81 | 41 | 0.506 | 23199 | 6706 | 0.289 |
3 | 451 | 12554 | 35615 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Chemical Sciences
Homogeneous catalysis | reaction mechanisms | molecular modeling | |
187 | 87 | 0.465 | 67 | 33 | 0.493 | 12538 | 3620 | 0.289 |
4 | 478 | 13303 | 37675 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Cardiology
cardiology | lipids | hypertension | |
182 | 51 | 0.280 | 56 | 27 | 0.482 | 11193 | 2583 | 0.231 |
5 | 514 | 14167 | 40125 |
|
Sweden | AstraZeneca, Sweden |
Others
Drug metabolism and disposition | |
176 | 77 | 0.438 | 73 | 37 | 0.507 | 20228 | 5444 | 0.269 |
6 | 607 | 16646 | 46908 |
|
Sweden | AstraZeneca, Sweden |
Engineering & Technology / Computer Science
Data Science | |
162 | 132 | 0.815 | 55 | 42 | 0.764 | 13760 | 6951 | 0.505 |
7 | 778 | 21289 | 59631 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Medical Oncology
Oncology | |
142 | 127 | 0.894 | 74 | 60 | 0.811 | 24505 | 14382 | 0.587 |
8 | 816 | 22312 | 62477 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Mathematical Sciences
statistics | clinical trials | regulatory submission for drug development | |
139 | 73 | 0.525 | 53 | 37 | 0.698 | 14749 | 4163 | 0.282 |
9 | 912 | 24452 | 68294 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Molecular Biology & Genetics
CAR-T | Treg | iPSC | genome editing | lentiviral and AAV vectors | |
132 | 72 | 0.545 | 54 | 28 | 0.519 | 10176 | 3240 | 0.318 |
10 | 916 | 24532 | 68519 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Anesthesiology and Reanimation
Quantitative Clinical Pharmacology | Anesthesiology | Pharmacometrics | Clinical Pharmacology | |
132 | 40 | 0.303 | 67 | 21 | 0.313 | 16599 | 1643 | 0.099 |
Click for INSTITUTIONAL REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
11 | 935 | 25181 | 70343 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Molecular Biology & Genetics
Genomics | Bioinformatics | Oncology | Data Science | |
130 | 43 | 0.331 | 47 | 27 | 0.574 | 37293 | 7252 | 0.194 |
12 | 963 | 25990 | 72558 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Chemical Sciences
Cheminformatics | Drug Discovery | Machine Learning | Semantic Web Technologies | Open Innovation | |
127 | 100 | 0.787 | 51 | 40 | 0.784 | 11241 | 8631 | 0.768 |
13 | 1020 | 27547 | 76844 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Chemical Sciences
Proteomics | Cell Biology | Bioanalytical Chemistry | |
123 | 82 | 0.667 | 53 | 36 | 0.679 | 10741 | 4777 | 0.445 |
14 | 1150 | 30518 | 84866 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Clinical Pharmacology | |
116 | 73 | 0.629 | 48 | 26 | 0.542 | 8001 | 3508 | 0.438 |
15 | 1269 | 34052 | 94220 |
|
Sweden | AstraZeneca, Sweden |
Others
Cancer | |
109 | 50 | 0.459 | 49 | 23 | 0.469 | 8137 | 2089 | 0.257 |
16 | 1276 | 34215 | 94634 |
|
Sweden | AstraZeneca, Sweden |
Others
Clinical Trials | Longitudinal Data | Evidence Synthesis | |
108 | 96 | 0.889 | 60 | 48 | 0.800 | 17463 | 10310 | 0.590 |
17 | 1386 | 37181 | 102585 |
|
Sweden | AstraZeneca, Sweden |
Others
|
103 | 71 | 0.689 | 52 | 34 | 0.654 | 9159 | 3557 | 0.388 |
18 | 1425 | 38286 | 105522 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Physiology
Physiology | Metabolism | Transgenic | CRISPR | |
101 | 78 | 0.772 | 47 | 34 | 0.723 | 16538 | 8078 | 0.488 |
19 | 1483 | 39714 | 109354 |
|
Sweden | AstraZeneca, Sweden |
Others
drug discovery and development | viruses and epithelial biology | non coding RNA | post translational modification | |
99 | 60 | 0.606 | 52 | 25 | 0.481 | 7634 | 1915 | 0.251 |
20 | 1638 | 43420 | 119329 |
|
Sweden | AstraZeneca, Sweden |
Others
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients | |
93 | 78 | 0.839 | 60 | 46 | 0.767 | 20990 | 10178 | 0.485 |
21 | 1677 | 44120 | 121138 |
|
Sweden | AstraZeneca, Sweden |
Others
meta-analysis | missing data | statistics | biostatistics | miscellaneous statistical theory | |
92 | 81 | 0.880 | 51 | 38 | 0.745 | 12774 | 8467 | 0.663 |
22 | 1863 | 48668 | 133296 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
Pharmacology | Drug Development | Pharmacokinetics | Modeling | |
87 | 18 | 0.207 | 39 | 12 | 0.308 | 5710 | 802 | 0.140 |
23 | 1917 | 50147 | 137340 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Chemical Sciences
medicinal chemistry | drug discovery | oncology & infectious diseases | |
85 | 46 | 0.541 | 39 | 25 | 0.641 | 10173 | 5368 | 0.528 |
24 | 1970 | 51380 | 140591 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Immunology
Immunotherapy | microbiome | and targeted therapy for oncology | |
83 | 75 | 0.904 | 54 | 44 | 0.815 | 22662 | 16421 | 0.725 |
25 | 1979 | 51615 | 141286 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Pharmacology
molecular pharmacology | oncology | |
83 | 61 | 0.735 | 45 | 28 | 0.622 | 20446 | 8739 | 0.427 |
26 | 2050 | 53733 | 147002 |
|
Sweden | AstraZeneca, Sweden |
Others
Cardiovascular | Drug Discovery & Development | |
81 | 40 | 0.494 | 48 | 21 | 0.438 | 7905 | 1418 | 0.179 |
27 | 2109 | 55519 | 151780 |
|
Sweden | AstraZeneca, Sweden |
Others
|
79 | 46 | 0.582 | 44 | 23 | 0.523 | 6425 | 2349 | 0.366 |
28 | 2112 | 55570 | 151891 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Chemical Sciences
Chemistry | |
79 | 44 | 0.557 | 34 | 20 | 0.588 | 4296 | 1590 | 0.370 |
29 | 2135 | 56050 | 153207 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Mathematical Sciences
replicability | reproduciblity | in-vivo | experimental design | sex bias | |
78 | 66 | 0.846 | 47 | 34 | 0.723 | 15482 | 10540 | 0.681 |
30 | 2220 | 58282 | 159336 |
|
Sweden | AstraZeneca, Sweden |
Others
Early Phase Oncology | |
76 | 57 | 0.750 | 35 | 25 | 0.714 | 4327 | 3073 | 0.710 |
A New and Different Feature!!!! University Subject Rankings in 12 subjects:Ranking and analysis of universities by subject in 12 fields such as health, engineering, natural sciences, education, business, economics, social sciences, etc. |
||||||||||||||||
31 | 2253 | 59166 | 161786 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Biological Science
From directed protein evolution to experimental medicine | |
75 | 61 | 0.813 | 44 | 31 | 0.705 | 7547 | 3298 | 0.437 |
32 | 2370 | 62048 | 169314 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Chemical Sciences
Medicinal Chemistry | Oncology | |
73 | 38 | 0.521 | 36 | 21 | 0.583 | 4214 | 1893 | 0.449 |
33 | 2384 | 62401 | 170138 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Molecular Biology & Genetics
bioinformatics | drug discovery | conserved non-coding elements | AI/ML | |
72 | 70 | 0.972 | 36 | 36 | 1.000 | 4885 | 4441 | 0.909 |
34 | 2418 | 63087 | 172020 |
|
Sweden | AstraZeneca, Sweden |
Others
|
72 | 44 | 0.611 | 45 | 28 | 0.622 | 6821 | 3432 | 0.503 |
35 | 2495 | 65127 | 177395 |
|
Sweden | AstraZeneca, Sweden |
Others
Diabetes | Cardiovascular disease | Heart failure | Kidney disease | Hypertension | |
70 | 57 | 0.814 | 36 | 30 | 0.833 | 5604 | 4002 | 0.714 |
36 | 2549 | 66242 | 180455 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Molecular Biology & Genetics
Precision Medicine | Drug Discovery | Digital Health | Computational Biology | Translational Bioinformatics | |
69 | 58 | 0.841 | 38 | 32 | 0.842 | 6322 | 4829 | 0.764 |
37 | 2551 | 66324 | 180703 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Molecular Biology & Genetics
genomics | genetics | oncology | DNA sequencing | bioinformatics | |
69 | 55 | 0.797 | 49 | 28 | 0.571 | 37354 | 7655 | 0.205 |
38 | 2564 | 66614 | 181421 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Molecular Biology & Genetics
Genetics | Cardiovascular Science | Physiology | Gene Expression | Cell survival | |
69 | 47 | 0.681 | 35 | 26 | 0.743 | 5207 | 1801 | 0.346 |
39 | 2569 | 66823 | 181936 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
pharmaceutical research | drug discovery | QSAR | |
69 | 39 | 0.565 | 39 | 20 | 0.513 | 8134 | 2094 | 0.257 |
40 | 2570 | 66846 | 181989 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Biological Science
Proteomics | Metabolomics | Mass Spectrometry | |
69 | 38 | 0.551 | 39 | 19 | 0.487 | 7780 | 1362 | 0.175 |
41 | 2597 | 67461 | 183721 |
|
Sweden | AstraZeneca, Sweden |
Others
|
68 | 58 | 0.853 | 40 | 31 | 0.775 | 4965 | 2775 | 0.559 |
42 | 2603 | 67535 | 183921 |
|
Sweden | AstraZeneca, Sweden |
Others
Sustainability | Environmental Risk Assessment | Persistence Assessment | Antimicrobial Resistance | Biodegradability | |
68 | 56 | 0.824 | 40 | 33 | 0.825 | 9285 | 4865 | 0.524 |
43 | 2614 | 67766 | 184540 |
|
Sweden | AstraZeneca, Sweden |
Engineering & Technology / Chemical Engineering
Chemical Engineering | Process Engineering | Pharmaceutical Engineering | Modelling | Simulation | |
68 | 50 | 0.735 | 31 | 23 | 0.742 | 3144 | 1703 | 0.542 |
44 | 2693 | 69985 | 190363 |
|
Sweden | AstraZeneca, Sweden |
Others
MS imaging | molecular imaging | |
66 | 62 | 0.939 | 37 | 31 | 0.838 | 4327 | 2977 | 0.688 |
45 | 2784 | 72326 | 196725 |
|
Sweden | AstraZeneca, Sweden |
Medical and Health Sciences / Cardiovascular Surgery
Heart failure | drug discovery | cardiac regeneration | stem cell | |
65 | 34 | 0.523 | 35 | 24 | 0.686 | 4210 | 2359 | 0.560 |
46 | 2842 | 73894 | 200903 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Chemical Sciences
Drug Discovery | Medicinal Chemistry | Organic Chemistry | Pharmacology | |
64 | 30 | 0.469 | 39 | 17 | 0.436 | 4467 | 835 | 0.187 |
47 | 2865 | 74421 | 202324 |
|
Sweden | AstraZeneca, Sweden |
Natural Sciences / Biological Science
Ecotoxicology | 3Rs | Environmental Safety | |
63 | 56 | 0.889 | 38 | 28 | 0.737 | 4412 | 2579 | 0.585 |
48 | 2896 | 75600 | 205403 |
|
Sweden | AstraZeneca, Sweden |
Others
arrhythmias | heart failure | |
63 | 19 | 0.302 | 38 | 14 | 0.368 | 6338 | 1409 | 0.222 |
49 | 2906 | 75872 | 206217 |
|
Sweden | AstraZeneca, Sweden |
Others
Lipoproteins | Coronary artery disease | Heart failure | Inflammation | Cardiovascular disease | |
62 | 56 | 0.903 | 36 | 30 | 0.833 | 4425 | 3195 | 0.722 |
50 | 2917 | 76076 | 206925 |
|
Sweden | AstraZeneca, Sweden |
Others
Lymphocyte Biology | Lymphomagenesis | Therapeutics | |
62 | 50 | 0.806 | 46 | 36 | 0.783 | 22829 | 8990 | 0.394 |